REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) (Egypt)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Glaxosmithkline S.A.E. Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) is an enterprise based in Egypt. Its main office is in Cairo. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on April 01, 1981. It currently has a total number of 775 (2022) employees. From the latest financial highlights, Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) reported a net sales revenue increase of 24.73% in 2025. A growth of 23.23% was recorded in its total assets. The enterprise’s net profit margin decreased by 0.1% in 2025.

Legal Address
Boomerang Building, No 46, Block (J) First Section City Centre, Fifth District, New Cairo
Cairo; Greater Cairo; Postal Code: 11835

Contact Details: Purchase the Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) report to view the information.

Basic Information
Total Employees:
Purchase the Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) report to view the information.
Outstanding Shares:
Purchase the Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) report to view the information.
Registered Capital:
Purchase the Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) report to view the information.
Financial Auditors:
Purchase the Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) report to view the information.
Incorporation Date:
April 01, 1981
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
91.2%
Company Performance
Financial values in the chart are available after Glaxosmithkline S.A.E. (جلاكسو سميث كلاين) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
24.73%
Total Operating Revenue
24.66%
Operating Profit
-40.25%
EBITDA
-37.56%
Net Profit/Loss for the Period
22.56%
Total Assets
23.23%
Total Equity
11.11%
Operating Profit Margin
-11.47%
Net Profit Margin
-0.1%
Return on Equity (ROE)
0.9%
Quick Ratio
-235.63%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?